Breaking Finance News

C R Bard Inc (NYSE:BCR) has been upgraded to Strong-Buy in a statement by BidaskClub earlier today.

Having a price of $318.41, C R Bard Inc (NYSE:BCR) traded 0.19% higher on the day. With the last close up 12.81% from the two hundred day average, compared with the S&P 500 Index which has increased 0.05% over the same period. C R Bard Inc has recorded a 50-day average of $319.00 and a two hundred day average of $283.44. Volume of trade was down over the average, with 330,226 shares of BCR changing hands under the typical 669,155

BidaskClub has upgraded C R Bard Inc (NYSE:BCR) to Strong-Buy in a statement released on 7/08/2017.

On 6/21/2017, Zacks Investment Research released a statement on C R Bard Inc (NYSE:BCR) upped the target price from $0.00 to $353.00 that suggested an upside of 0.12%.

Performance Chart

C R Bard Inc (NYSE:BCR)

With a total market value of $0, C R Bard Inc has price-earnings ratio of 41.98 with a one year low of $203.63 and a one year high of $323.27 .

A total of 14 equity analysts have released a ratings update on BCR. Two brokerages rating the company a strong buy, four brokerages rating the company a buy, fourteen brokerages rating the company a hold, zero brokerages rating the company a underperform, and finally zero brokerages rating the company a sell with a 12-month price target of $226.21.

General Information About C R Bard Inc (NYSE:BCR)

C. R. Bard, Inc. (Bard) is engaged in designing, manufacturing, packaging, distribution and sale of medical, surgical, diagnostic and patient care devices. The Company operates through the manufacture and sale of medical devices segment. It sells a range of products to hospitals, individual healthcare professionals, extended care facilities and alternate site facilities on a global basis. Its vascular products cover a range of minimally invasive devices for the treatment of peripheral vascular disease and end-stage renal disease. Its urology products include basic urology drainage products, fecal and urinary continence products, urological specialty products and Targeted Temperature Management products. Its oncology products cover a range of devices used in the treatment and management of various cancers, and other diseases and disorders. Its surgical specialty products include implanted patches and fixation devices for hernia and soft tissue repairs.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with's FREE daily email newsletter.